BioLife Solutions, Inc. (BLFS) vs Immunome, Inc. (IMNM)
A side-by-side comparison of BioLife Solutions, Inc. and Immunome, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BLFS
BioLife Solutions, Inc.
$38.61HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
IMNM
Immunome, Inc.
$20.45HealthcareDelayed quote: Oct 6, 2026, 11:00 AM EDT
Total return — BLFS vs IMNM
growth of $100 · dividends reinvested · last 6yBLFS +47.9% (+6.7%/yr)IMNM +57.4% (+7.9%/yr)IMNM compounded faster over this window
BLFS IMNM
BLFS vs IMNM: by the numbers
- •IMNM is the larger company ($1.95B vs $1.89B market cap).
- •BLFS is profitable (49.06% net margin) while IMNM runs a net loss (-3059.99%).
Metrics side by side
Valuation
| Metric | BLFS | IMNM |
|---|---|---|
| P/E ratio | 37.72 | N/A |
| Forward P/E | 64.35 | N/A |
| P/S ratio | 18.35 | N/A |
| P/B ratio | 4.49 | 3.72 |
| EV / EBITDA | 170.26 | N/A |
Profitability
| Metric | BLFS | IMNM |
|---|---|---|
| Gross margin | 64.48% | 57.43% |
| Operating margin | -1.12% | -3084.76% |
| Net margin | 49.06% | -3059.99% |
| ROE | 12.01% | -48.43% |
| ROIC | 1.72% | -51.06% |
Growth (annualized)
| Metric | BLFS | IMNM |
|---|---|---|
| Revenue CAGR (5Y) | 6.78% | N/A |
| Total return CAGR (5Y) | -0.77% | 2.88% |
Frequently asked
- Is BLFS or IMNM more profitable?
- BLFS runs the higher net margin — BLFS at 49.06% versus IMNM at -3059.99%.
- How have BLFS and IMNM total returns compared?
- Over the past 5 years, BLFS delivered -0.77% and IMNM delivered 2.88% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
BioLife Solutions P/E ratioBioLife Solutions ROEImmunome ROEBioLife Solutions operating marginImmunome operating marginBioLife Solutions revenue growthImmunome revenue growthBioLife Solutions free cash flowImmunome free cash flow
BioLife Solutions & Immunome appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.